Global Type 1 Diabetes (T1D) Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

  • receipt Report ID : 137223
  • calendar_today Published On: Jan, 2019
  • file_copy Pages: 129
  • list Pharmaceuticals and Healthcare

Type 1 diabetes (T1D) is an autoimmune disease that occurs when a person’s pancreas stops producing insulin, the hormone that controls blood-sugar levels. T1D develops when the insulin-producing pancreatic beta cells are mistakenly destroyed by the body’s immune system. The cause of this attack is still being researched, however scientists believe the cause may have genetic and environmental components.

Scope of the Report:

This report focuses on the Type 1 Diabetes (T1D) in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Sedentary lifestyle, unhealthy diet, lack of exercise and increasing prevalence of diabetes are key driver for Type 1 Diabetes (T1D) market. Insulin therapy is very much essential in the patients who have type 1 diabetes. Rising launch of the novel insulin formulations along with several adjunct therapies will positively impact the insulin acceptance. On the other hand, this chronic disorder poses a significant economic impact owing to the increasing cost of insulin coupled with other conditions such as cardiac disorders, kidney disease among others. While insulin therapy keeps people with T1D alive and can help keep blood-glucose levels within recommended range, it is not a cure, nor does it prevent the possibility of T1D’s serious effects. Although T1D is a serious and challenging disease, long-term management options continue to evolve, allowing those with T1D to have full and active lives. Asia Pacific region recorded the highest growth rate over the forecast period owing to the increasingly sedentary lifestyles, obese population, and improper food habits. North America accounted for more than 50% of the total market share over the forecast period.

The worldwide market for Type 1 Diabetes (T1D) is expected to grow at a CAGR of roughly 4.4% over the next five years, will reach 2540 million US$ in 2023, from 1960 million US$ in 2017, according to a new study.

Market Segment by Manufacturers, this report covers

Novo Nordisk

Sanofi

Eli Lilly

Merck

Boehringer Ingelheim

Samsung Bioepis

Biocon

Astellas

Janssen

Bristol-Myers Squibb

Lexicon

Sanofi

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Rapid Acting Insulin Analogs

Long Acting Insulin Analogs

Premix Insulin Analogs

Market Segment by Applications, can be divided into

Children

Adults

There are 15 Chapters to deeply display the global Type 1 Diabetes (T1D) market.

Chapter 1, to describe Type 1 Diabetes (T1D) Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Type 1 Diabetes (T1D), with sales, revenue, and price of Type 1 Diabetes (T1D), in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Type 1 Diabetes (T1D), for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Type 1 Diabetes (T1D) market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Type 1 Diabetes (T1D) sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Market Overview

1.1 Type 1 Diabetes (T1D) Introduction

1.2 Market Analysis by Type

1.2.1 Rapid Acting Insulin Analogs

1.2.2 Long Acting Insulin Analogs

1.2.3 Premix Insulin Analogs

1.3 Market Analysis by Applications

1.3.1 Children

1.3.2 Adults

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Novo Nordisk

2.1.1 Business Overview

2.1.2 Type 1 Diabetes (T1D) Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Novo Nordisk Type 1 Diabetes (T1D) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Sanofi

2.2.1 Business Overview

2.2.2 Type 1 Diabetes (T1D) Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Sanofi Type 1 Diabetes (T1D) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Eli Lilly

2.3.1 Business Overview

2.3.2 Type 1 Diabetes (T1D) Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Eli Lilly Type 1 Diabetes (T1D) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Merck

2.4.1 Business Overview

2.4.2 Type 1 Diabetes (T1D) Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Merck Type 1 Diabetes (T1D) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Boehringer Ingelheim

2.5.1 Business Overview

2.5.2 Type 1 Diabetes (T1D) Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Boehringer Ingelheim Type 1 Diabetes (T1D) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Samsung Bioepis

2.6.1 Business Overview

2.6.2 Type 1 Diabetes (T1D) Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Samsung Bioepis Type 1 Diabetes (T1D) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 Biocon

2.7.1 Business Overview

2.7.2 Type 1 Diabetes (T1D) Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Biocon Type 1 Diabetes (T1D) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8 Astellas

2.8.1 Business Overview

2.8.2 Type 1 Diabetes (T1D) Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Astellas Type 1 Diabetes (T1D) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.9 Janssen

2.9.1 Business Overview

2.9.2 Type 1 Diabetes (T1D) Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Janssen Type 1 Diabetes (T1D) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.10 Bristol-Myers Squibb

2.10.1 Business Overview

2.10.2 Type 1 Diabetes (T1D) Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Bristol-Myers Squibb Type 1 Diabetes (T1D) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.11 Lexicon

2.11.1 Business Overview

2.11.2 Type 1 Diabetes (T1D) Type and Applications

2.11.2.1 Product A

2.11.2.2 Product B

2.11.3 Lexicon Type 1 Diabetes (T1D) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.12 Sanofi

2.12.1 Business Overview

2.12.2 Type 1 Diabetes (T1D) Type and Applications

2.12.2.1 Product A

2.12.2.2 Product B

2.12.3 Sanofi Type 1 Diabetes (T1D) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Type 1 Diabetes (T1D) Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Type 1 Diabetes (T1D) Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Type 1 Diabetes (T1D) Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Type 1 Diabetes (T1D) Manufacturer Market Share in 2017

3.3.2 Top 6 Type 1 Diabetes (T1D) Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Type 1 Diabetes (T1D) Market Analysis by Regions

4.1 Global Type 1 Diabetes (T1D) Sales, Revenue and Market Share by Regions

4.1.1 Global Type 1 Diabetes (T1D) Sales and Market Share by Regions (2013-2018)

4.1.2 Global Type 1 Diabetes (T1D) Revenue and Market Share by Regions (2013-2018)

4.2 North America Type 1 Diabetes (T1D) Sales and Growth Rate (2013-2018)

4.3 Europe Type 1 Diabetes (T1D) Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Type 1 Diabetes (T1D) Sales and Growth Rate (2013-2018)

4.5 South America Type 1 Diabetes (T1D) Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Type 1 Diabetes (T1D) Sales and Growth Rate (2013-2018)

5 North America Type 1 Diabetes (T1D) by Countries

5.1 North America Type 1 Diabetes (T1D) Sales, Revenue and Market Share by Countries

5.1.1 North America Type 1 Diabetes (T1D) Sales and Market Share by Countries (2013-2018)

5.1.2 North America Type 1 Diabetes (T1D) Revenue and Market Share by Countries (2013-2018)

5.2 United States Type 1 Diabetes (T1D) Sales and Growth Rate (2013-2018)

5.3 Canada Type 1 Diabetes (T1D) Sales and Growth Rate (2013-2018)

5.4 Mexico Type 1 Diabetes (T1D) Sales and Growth Rate (2013-2018)

6 Europe Type 1 Diabetes (T1D) by Countries

6.1 Europe Type 1 Diabetes (T1D) Sales, Revenue and Market Share by Countries

6.1.1 Europe Type 1 Diabetes (T1D) Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Type 1 Diabetes (T1D) Revenue and Market Share by Countries (2013-2018)

6.2 Germany Type 1 Diabetes (T1D) Sales and Growth Rate (2013-2018)

6.3 UK Type 1 Diabetes (T1D) Sales and Growth Rate (2013-2018)

6.4 France Type 1 Diabetes (T1D) Sales and Growth Rate (2013-2018)

6.5 Russia Type 1 Diabetes (T1D) Sales and Growth Rate (2013-2018)

6.6 Italy Type 1 Diabetes (T1D) Sales and Growth Rate (2013-2018)

7 Asia-Pacific Type 1 Diabetes (T1D) by Countries

7.1 Asia-Pacific Type 1 Diabetes (T1D) Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Type 1 Diabetes (T1D) Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Type 1 Diabetes (T1D) Revenue and Market Share by Countries (2013-2018)

7.2 China Type 1 Diabetes (T1D) Sales and Growth Rate (2013-2018)

7.3 Japan Type 1 Diabetes (T1D) Sales and Growth Rate (2013-2018)

7.4 Korea Type 1 Diabetes (T1D) Sales and Growth Rate (2013-2018)

7.5 India Type 1 Diabetes (T1D) Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Type 1 Diabetes (T1D) Sales and Growth Rate (2013-2018)

8 South America Type 1 Diabetes (T1D) by Countries

8.1 South America Type 1 Diabetes (T1D) Sales, Revenue and Market Share by Countries

8.1.1 South America Type 1 Diabetes (T1D) Sales and Market Share by Countries (2013-2018)

8.1.2 South America Type 1 Diabetes (T1D) Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Type 1 Diabetes (T1D) Sales and Growth Rate (2013-2018)

8.3 Argentina Type 1 Diabetes (T1D) Sales and Growth Rate (2013-2018)

8.4 Colombia Type 1 Diabetes (T1D) Sales and Growth Rate (2013-2018)

9 Middle East and Africa Type 1 Diabetes (T1D) by Countries

9.1 Middle East and Africa Type 1 Diabetes (T1D) Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Type 1 Diabetes (T1D) Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Type 1 Diabetes (T1D) Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Type 1 Diabetes (T1D) Sales and Growth Rate (2013-2018)

9.3 UAE Type 1 Diabetes (T1D) Sales and Growth Rate (2013-2018)

9.4 Egypt Type 1 Diabetes (T1D) Sales and Growth Rate (2013-2018)

9.5 Nigeria Type 1 Diabetes (T1D) Sales and Growth Rate (2013-2018)

9.6 South Africa Type 1 Diabetes (T1D) Sales and Growth Rate (2013-2018)

10 Global Type 1 Diabetes (T1D) Market Segment by Type

10.1 Global Type 1 Diabetes (T1D) Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Type 1 Diabetes (T1D) Sales and Market Share by Type (2013-2018)

10.1.2 Global Type 1 Diabetes (T1D) Revenue and Market Share by Type (2013-2018)

10.2 Rapid Acting Insulin Analogs Sales Growth and Price

10.2.1 Global Rapid Acting Insulin Analogs Sales Growth (2013-2018)

10.2.2 Global Rapid Acting Insulin Analogs Price (2013-2018)

10.3 Long Acting Insulin Analogs Sales Growth and Price

10.3.1 Global Long Acting Insulin Analogs Sales Growth (2013-2018)

10.3.2 Global Long Acting Insulin Analogs Price (2013-2018)

10.4 Premix Insulin Analogs Sales Growth and Price

10.4.1 Global Premix Insulin Analogs Sales Growth (2013-2018)

10.4.2 Global Premix Insulin Analogs Price (2013-2018)

11 Global Type 1 Diabetes (T1D) Market Segment by Application

11.1 Global Type 1 Diabetes (T1D) Sales Market Share by Application (2013-2018)

11.2 Children Sales Growth (2013-2018)

11.3 Adults Sales Growth (2013-2018)

12 Type 1 Diabetes (T1D) Market Forecast (2018-2023)

12.1 Global Type 1 Diabetes (T1D) Sales, Revenue and Growth Rate (2018-2023)

12.2 Type 1 Diabetes (T1D) Market Forecast by Regions (2018-2023)

12.2.1 North America Type 1 Diabetes (T1D) Market Forecast (2018-2023)

12.2.2 Europe Type 1 Diabetes (T1D) Market Forecast (2018-2023)

12.2.3 Asia-Pacific Type 1 Diabetes (T1D) Market Forecast (2018-2023)

12.2.4 South America Type 1 Diabetes (T1D) Market Forecast (2018-2023)

12.2.5 Middle East and Africa Type 1 Diabetes (T1D) Market Forecast (2018-2023)

12.3 Type 1 Diabetes (T1D) Market Forecast by Type (2018-2023)

12.3.1 Global Type 1 Diabetes (T1D) Sales Forecast by Type (2018-2023)

12.3.2 Global Type 1 Diabetes (T1D) Market Share Forecast by Type (2018-2023)

12.4 Type 1 Diabetes (T1D) Market Forecast by Application (2018-2023)

12.4.1 Global Type 1 Diabetes (T1D) Sales Forecast by Application (2018-2023)

12.4.2 Global Type 1 Diabetes (T1D) Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Type 1 Diabetes (T1D) Picture

Table Product Specifications of Type 1 Diabetes (T1D)

Figure Global Sales Market Share of Type 1 Diabetes (T1D) by Types in 2017

Please fill the form below, to recieve the report sample


+1